Mometasonfuroat Sandoz, Nasenspray

7680618990011 CH-61899 Nasenspray
Mometasonfuroat Sandoz, Nasenspray
Mometasonfuroat Sandoz, Nasenspray
Mometasonfuroat Sandoz, Nasenspray
1 / 3
google

Article details

Package size
140
Selling units
140
Measure
Einzeldose(n)
Galenic form
Nasenspray
Galenic group
Nasenmittel

Official Swissmedic V2 data

Additional information from the official database

Official medical documents

Patient information leaflet
Allemand
29/07/2022
Patient information leaflet
Français
29/07/2022
Patient information leaflet
Italien
29/07/2022
Summary of Product Characteristics
Allemand
29/07/2022
Summary of Product Characteristics
Français
29/07/2022
Summary of Product Characteristics
Italien
29/07/2022

Detailed composition

Substance Quantity Type Category
(N/A)
0.5 MG Substance Wirkstoff (Principe actif)
(N/A)
0.51731 MG Substance WIZUS
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
0.2 MG Substance HBESI
(N/A)
- Substance HNIDK
(N/A)
50.0 UG Substance Wirkstoff (Principe actif)

Reimbursement information

Public price
CHF 17.65
Specialties list
Yes
Generic
Yes
SL addition date: 01/01/2014

Authorization holder

Sandoz Pharmaceuticals AG

6343 Risch

Authorization information

Swissmedic authorization number
61899
Drug name
Mometasonfuroat Sandoz, Nasenspray
Galenic form
NASSS
ATC Code
R01AD09
Authorization status
Z
Dispensing category
B
First authorization
04/04/2012
Authorization expiration date
31/12/9999
IT Number
12.02.3.
Domain
Human medicine
Field of application
Rhinitis, Nasenpolypen

Package details

Description (FR)
FUROATE MOMETASON Sandoz 50 mcg spr dos 140 dos
Description (DE)
MOMETASONFUROAT Sandoz 50 mcg Dosierspr 140 Dos
Market launch
04/04/2012
Narcotic (BTM)
No

Original drug

Nasonex, Dosier-Nasenspray
GTIN: 7680541890365
CHF 18.45
View original

Other package sizes (1)

FUROATE MOMETASON Sandoz 50 mcg 3 spr dos 140 dos
3x 140 EINZ
GTIN: 7680618990028
View